ABOUT THE REGISTRATION:
- There will only be one registration per email/ID number;
- The subscription is individual and non-transferable;
- Registration must be made electronically only from 04/01/2024 to 06/07/2024;
- Abstract submission will be from 04/01/2024 to 05/12/2024 until 11:59 h PM (GMT-3);
- All information will be automatically sent to the email address used to register on the Even3 platform.
- If you already have an e-mail registered on the Even3 platform, use the same e-mail to register on the 5th CDNB.
THE REGISTERED PARTICIPANT WILL BE ENTITLED TO:
- Access the complete schedule of the 5th CDNB on the website before the start of the event;
- Have access to the Digital Certificate of Participation in the 5th CDNB by e-mail or website (accreditation in at least 75% of the activities*);
- Submit one (01) abstract as first authorship; and, if selected and presented, have access to the Digital Certificate of e-Poster Presentation by e-mail, for registrants with abstract submission (submission only to the first author);
- Submit one (01) elevator pitch as responsible; and if selected and displayed, have access to the Digital Certificate of Presentation of elevator pitch by email, for registrants with submission of pitch video (sending only to the person in charge);
- Access all event activities online.
*Activities accounted for: Scientific lectures (minimum of 12 scientific lectures registered and accredited).
APPLICATION PERIOD:
With abstract: from 04/01/2024 to 05/12/2024 until 11:59 PM (GMT-3) (or until places are sold out - 150 abstracts).
No abstract: from 04/01/2024 to 06/07/2024.
With pitch: from 04/01/2024 to 05/30/2024.
Instructions for preparing an abstract
1. INITIAL INSTRUCTIONS (SUBMISSIONS CLOSED)
a. Only abstracts of original experimental studies will be accepted (no type of literature review will be accepted) on the following topics*:
1. Nanobiotechnology / Bionanotechnology
- Nanoagriculture
- Nanofoods
- Nanoenvironmental
- Nanobiocharacterization
- Nanocosmetics
- Nanomedicine
- Nanosafety
- Nanogreen
2. Tissue Bioengineeringl
- 3D Biofabrication
- 3D Bioprinting
- Biomaterials
- Biomimetics
- Cultured meat
b. Abstract submission is free.
c. Only abstracts will be accepted that:
Are submitted within the deadline established by the organization of the event (04/01/2024 to 05/12/2024) until 11:59 h PM (GMT-3);
Are within the limit of 150 abstracts to be received by the 5th CDNB Organizing Team;
Are directly related to any of the thematic areas/subareas covered in the 5th CDNB (see glossary);
Follow the rules for the preparation of abstracts established by the Organizing Team;
The submitter must complete and sign on behalf of all other authors the license for the use of the work (1st page of the abstract template) and the declaration regarding the observance and compliance with the law n° 13.123/2015 and other regulatory frameworks related to the result (2nd page of the summary template).
d. Each participant can submit only 1 (one) abstract as first author, and may be co-author of other abstracts. All authors are responsible for the content, originality and veracity of the information contained in the submitted abstracts;
e. The abstract should be sent only via Google Forms after sign-up. If a participant submits an abstract without being registered for the event, this submission will be disregarded, and if they submit more than one abstract as first authorship, only the first one will be evaluated;
f. The submitted abstract will be analyzed by the Scientific Committee of the 5th CDNB and the partial result will be sent to the person responsible for the submission by e-mail until the day 05/19/2024, and the final result by day 05/26/2024;
g. The analysis by the Scientific Committee of the 5th CDNB will cover the following aspects: clearly defined objectives, appropriate methodology, clearly presented results and relevant conclusions;
h. The quality of the text (grammar and spelling) is the sole responsibility of the authors and will be considered as an evaluation criterion;
i. Only 01 (one) certificate will be issued for each abstract accepted and presented as an e-Poster/recording. It will contain the title of the work, the name of the first author and the other co-authors as informed in the act of submission. Authorship changes will not be accepted after submission;
j. All accepted abstracts must be presented orally (Kumospace) to receive the presentation certificate and be published in the 5th CDNB Book of Abstracts.
k. Three (3) abstracts will be selected from each thematic area (Nanobiotechnology and Bioengineering), which will receive an honorable mention at the end of the event. The mention will be governed by this regulation, and it will be up to the Scientific Committees or Organizing Team, by consensus, or majority of votes, to decide on omissions, and the score of each work will not be disclosed. Papers will be evaluated based on the following criteria:
- Suitability to the theme, 10 points (5 points written evaluation + 5 points oral evaluation);
- Timeliness of the approach, 10 points (5 points written assessment + 5 points oral assessment);
- Relevance of the study, 20 points (10 points written assessment + 10 points oral assessment);
- Research innovation, 20 points (10 points written assessment + 10 points oral assessment);
- Correctness, clarity, conciseness, and objectivity of written language, 10 points;
- Mastery of the topic and clarity of the oral presentation, 20 points;
- Appropriate to the time of the oral presentation, 10 points.
2. ABSTRACT INSTRUCTIONS
a. The abstracts should be written in Portuguese or English;
b. The title must include the overview of the abstract and must contain a maximum of 120 characters with spaces;
c. The abstract will contain a maximum of 1500 characters including spaces;
d. The abstract must be about the study you want to present (of your authorship), presented in running text;
e. The abstract should include: brief introduction of the work, objective, methodology used, results obtained and conclusion, but no subtopics should be added;
f. ABSTRACTS REFERRING TO RESEARCH PROJECTS WITHOUT PRESENTED RESULTS WILL NOT BE ACCEPTED. LITERATURE REVIEWS OF ANY KIND WILL NOT BE ACCEPTED;
g. The abstract must be submitted strictly according to the model below and instructions;
h. To submit the abstract (5 steps):
- DOWNLOAD TEMPLATE HERE (.docx): Portuguese / English
- Fill out and sign the license for the use of the work (1st page) and the declaration regarding the observance and compliance with law n° 13.123/2015 and other regulatory frameworks related to the result (2nd page), your abstract will only be evaluated if these documents are duly completed and signed;
- Fill in the template as instructed;
- Rename the document to YourFullName, example: John Smith;
- Sign up for 5th CDNB and submit your abstract at Google Forms until 05/12/2024 until 11:59 h PM (GMT-3)
i. Your signature on the license term for the use of the work must be digital:
- Sign a blank sheet;
- Scan your signature (crop it so it's well centered);
- Add your signature on the document in the indicated field.
Instructions for preparing e-posters, recording presentations, and oral presentations
1. INSTRUCTIONS FOR PREPARING THE e-POSTER:
a. The e-Poster must be written in Portuguese or English;
b. Authors who have their abstracts approved must send their e-Poster in PDF format until 06/04/2024 at 11:59 PM (GMT-3) exclusively through the Google form (LINK: To be sent later). E-posters sent by email will not be accepted.
c. Your presentation area is free to use fonts, letters, sizes and colors of your choice, as long as it respects the size of 1 (one) slide (33.867 cm wide x 19.05 cm high). You can use figures, diagrams, or tables of your own for presentation, however, remember that all the information contained therein must be visible and legible;
d. Within the e-Poster area, the author will have to organize his entire presentation (title, introduction, objective, methodology, results and conclusion). Presentations on multiple slides or with dimensions different from those indicated will be rejected;
2. INSTRUCTIONS FOR RECORDING THE VIDEO OF THE PRESENTATION
a. The video consists of a screen recording where the author presents his e-Poster orally for up to 5 (five) minutes, with the image of the e-poster, audio and camera. Videos recorded with a duration longer than indicated will be refused;
b. The recording can be made on the author's preferred platform: Zoom, Loom, Power Point, among others;
c. The video must be sent (in .mp4 or .avi format) via Google Forms (LINK: to be sent by email) until 11:59 PM on 06/04/2024. The e-Poster must also be sent at this same link in PDF format. Files must be named with the presenter's full name;
d. Video must be no larger than 10 MB (ten megabytes). Recordings larger than this size will be automatically rejected by the submission form. The Organizing Team carried out several tests on the most varied platforms that demonstrated the feasibility of recording a video with a duration of 5 minutes in this file size. It is the sole responsibility of each author to select the recording tool that is compatible with the indicated size;
e. The videos will be evaluated by the Scientific Committee according to the criteria mentioned above.
3. BROADCAST DAY INSTRUCTION:
a. The video broadcast and Q&A moments will take place during the 5th CDNB on the June 12th to 14th, 2024 in the morning (09:00 to 12:00 PM) at Kumospace;
b. The day and time will be informed by the Organizing Team via email until 06/09/2024 and it will await the author's knowledge;
c. The Scientific Committee will have up to 5 (five) minutes of questioning for the author on the day of the presentation. The author must be present in the Kumospace virtual room on the day of the exhibition of his video during the entire period established for the session in which he will present.
4. FINAL INSTRUCTIONS:
a. All data, images, graphs and other information contained in the slides or presented in oral form are the sole responsibility of the presenter who will make audience the content;
b. The e-Posters and videos will be available indefinitely on any social media of the 5th CDNB;
c. The presentations and Q&A sessions will be recorded and may be used for dissemination purposes on social media and the Digital Congress on Nanobiotechnology and Bioengineering Channel.
Elevator Pitch
Elevator Pitch Preparation Instructions
ABOUT ELEVATOR PITCH:
a. An elevator pitch is a brief presentation of an idea, project, product, process, or service, designed to be delivered in the short amount of time that an elevator ride offers, usually between 30 seconds and 1 minute. The goal is to arouse the interest of the listener, whether they are a potential investor, customer or partner, presenting in a concise and impactful way the value and uniqueness of the proposal.
b. The concept of elevator pitch applies to a wide range of professionals, including entrepreneurs, startups, vendors, researchers, and any individual who needs to quickly communicate the value of an idea or innovation. It is especially relevant for those seeking funding, support, or strategic partnerships, providing an opportunity to make a memorable first impression.
c. The relevance of the elevator pitch lies in its effectiveness in quickly conveying the essence of a proposal, maximizing impact in a short time. In a world where attention is a scarce resource, being able to capture and retain the interest of potential stakeholders efficiently is crucial. A good elevator pitch should be able to: Highlight Problem: Clearly present the problem or need that the proposal aims to solve; Propose the solution: Succinctly describe how the product, service, or idea solves this problem effectively; Show Differentials: Highlight what makes the proposal unique in relation to other solutions on the market; Arouse Interest: Generate enough curiosity and interest to motivate a more in-depth conversation after the pitch.
d. Submission of pitches is free.
e. Only pitches will be accepted that:
Are submitted within the deadline established by the event organization (04/01/2024 to 05/30/2024) until 11:59 h PM (GMT-3);
Are within the limit of 50 pitches to be received by the 5th CDNB Organizing Team;
Are directly related to any of the thematic areas/subareas covered in the 5th CDNB (see glossary);
Follow the rules for preparing pitches established by the Organizing Team;
The submitter fills out the form and authorizes the release of the pitch.
f. Each participant can submit a video of only 1 (one) pitch with a duration of up to 60 seconds (sixty seconds). The person responsible for the submission is fully responsible for the content of the pitch and all legal aspects related to the dissemination of the idea;
f. The elevator pitch should be written in Portuguese or English. There are no restrictions on the format of the presentation of up to 60 seconds recorded on video, which must have a maximum of 10 MBytes. The recording can be done on the presenter's preferred platform, such as Zoom, Loom, Power Point, among others;
h. Sonly pitches will be accepted in the following themes*:
1. Nanobiotechnology / Bionanotechnology
- Nanoagriculture
- Nanofoods
- Nanoenvironmental
- Nanobiocharacterization
- Nanocosmetics
- Nanomedicine
- Nanosafety
- Nanogreen
2. Tissue Bioengineering
- 3D Biofabrication
- 3D Bioprinting
- Biomaterials
- Biomimetic
- Cultured meat
h. It is recommended that the pitch submission person make sure that the pitch submission does not contain information that is sensitive or not adequately protected with respect to matters involving intellectual property. The 5th CDNB Organizing Team is not responsible for the dissemination or use of information presented;
j. The pitch should only be sent via Google Forms after registration. If a participant submits a pitch without being registered for the event, this submission will be disregarded, and if they submit more than one pitch, only the first one will be evaluated;
k. The submitted pitch will be analyzed by an Evaluation Committee (80% of the final grade) and Public (20% of the final grade), and the final result and classification (1st, 2nd, and 3rd placed) will be announced in the Closing Ceremony and on social media do 5th CDNB;
l. The analysis by the Evaluation Committee will cover the following criteria:
Is the Persona's pain clear?
Does the solution solve the Persona's pain?
Is the solution innovative?
Is the proposed business model viable?
Is the solution economically viable?
Is the solution socially just?
Is the solution environmentally friendly?
Is the probability of technical success high?
Is the payback probability ($) high?
Is the likelihood of adoption high?
m. All data, images, graphics and other information contained in the elevator pitches are the sole responsibility of the submitter.
This is an online event
